UiPath Unveils AI-Powered Medical Record Summarization Tool, Promising Significant Efficiency Gains in Healthcare

UiPath Unveils AI-Powered Medical Record Summarization Solution, Significantly Cuts Processing Time - UiPath (NYSE:PATH)

UiPath, Inc. PATH shares are trading higher on Wednesday. The company disclosed the launch of its generative AI-based UiPath Medical Record Summarization agent at Google Cloud Next 2025. The agent is currently in private preview and is powered by Google Cloud Vertex AI and Gemini models. It enables payer and provider organizations to leverage generative AI and automation for more efficient and accurate analysis of medical records. Developed in collaboration with clinical professionals, the agent offers a clinician-level, multi-point summarization of medical documents, completing the process in minutes instead of the typical 45 minutes required by manual data entry. Mark Geene, senior vice president of AI Products at UiPath said, "Chief medical officers, chief financial officers and CIOs at healthcare organizations are consistently under pressure to reduce costs and improve quality of care while dealing with people resource constraints. Currently, clinical and non-clinical staff must summarize large volumes of medical records, yet medical records lack standard formats and summaries meaning they vary in quality and standardization." The UiPath Medical Record Summarization agent cuts down on time spent on tasks like patient referral intake and utilization management reviews, saving up to 40 minutes per referral and reducing prior authorization turnaround time by up to 50%. The agent ensures consistent, high-quality summaries with standardized sections and traceable data, enhancing the accuracy of clinical decisions and minimizing errors. It also provides organized, structured medical records, allowing clinicians to make quicker, more informed decisions. Last month, the company reported fourth-quarter revenue of $424 million, which came short of the analyst consensus of $425.36 million, while EPS of nine cents beat the consensus estimate of three cents. Investors can gain exposure to the stock via Global X Robotics & Artificial Intelligence ETF BOTZ. PATH Price Action: UiPath shares are up 12.77% at $11.13 at publication Wednesday. Read Next: UiPath Hit By Slowing ARR Growth, Deal Timing Woes: Analyst Remains Optimistic For AI, Cloud Spark Photo: Shutterstock PATHUiPath Inc$11.1713.2%Stock Score Locked: Want to See it? Benzinga Rankings give you vital metrics on any stock - anytime. Reveal Full ScoreEdge RankingsMomentum20.10Growth72.24Quality-Value56.68Price TrendShortMediumLongOverviewBOTZGlobal X Robotics & Artificial Intelligence ETF$24.550.16%Got Questions? AskWhich healthcare organizations will adopt UiPath's AI?How might UiPath's solution affect medical record accuracy?What impact will automation have on healthcare costs?Which medical technology stocks could benefit from this trend?Are healthcare providers investing in AI solutions?How could clinical decision-making improve with AI?Which healthcare ETFs may gain from AI advancements?What is the potential for AI in medical processes overall?How will UiPath's partnership with Google Cloud influence growth?Who else in healthcare is exploring AI-driven solutions?Powered By This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors. Market News and Data brought to you by Benzinga APIs

UiPath Announces AI Partnership with Google Cloud to Transform Medical Processes

A new medical summarization AI agent will help healthcare organizations reduce overall prior authorization turn-around time by up to 50% UiPath will demo Vertex AI integration and showcase platform features to unlock end-to-end enterprise automation at Google Cloud Next booth #3323 UiPath (NYSE: PATH), a leading enterprise automation and AI software company, announced at Google Cloud Next 2025 the launch of its generative AI-based UiPath Medical Record Summarization agent, powered by Google Cloud Vertex AI and Gemini models. The UiPath Medical Record Summarization AI agent, now in private preview for customers, empowers both payer and provider organizations to take complete advantage of the combined power of gen AI and agentic automation. Developed in partnership with top clinical professionals, the solution leverages Google Gemini 2.0 Flash through Vertex AI to create a more efficient and accurate way to analyze medical documents. The agent is part of UiPath's strategy to provide vertical AI solutions tailored to specific industry needs. Built with UiPath Agent Builder, the agent provides a clinician-level, multi-point summarization of voluminous records at lower cost and with higher quality and accuracy than manual data entry, completing in just minutes a process that typically takes a medical professional an average of 45 minutes. This improves overall efficiency for healthcare organizations through: Reducing the time and effort required for manual summarization thereby increasing cost savings, lessening the need for rework, and improving revenue opportunities Significantly decreasing time spent on tasks such as patient referral intake, order intake, and utilization management reviews, saving up to 40 minutes per referral and reducing overall prior authorization turn-around time by up to 50% Ensuring medical summaries are consistent and high quality with standardized sections and traceable data, improving the accuracy of clinical decisions and reducing errors Providing a structured and organized summary of medical records, enabling clinicians and coordinators to make informed decisions more quickly and confidently "Chief Medical Officers, Chief Financial Officers, and CIOs at healthcare organizations are consistently under pressure to reduce costs and improve quality of care while dealing with people resource constraints. Currently, clinical and non-clinical staff must summarize large volumes of medical records, yet medical records lack standard formats and summaries meaning they vary in quality and standardization," said Mark Geene, senior vice president of AI Products at UiPath. "By automating and streamlining summary creation with Google Cloud, UiPath enables healthcare organizations to save clinical review time and improve accuracy, generating significant annual value in time savings and cost avoidance." "UiPath is delivering on its strategy to provide vertical AI solutions that are built to address industry-specific needs," said Shweta Maniar, global director for Healthcare & Life Science Strategy & Solutions at Google Cloud. "Powered by Vertex AI and Gemini models, UiPath's new medical summarization agent will significantly improve efficiency and streamline business processes for healthcare organizations." The new solution benefits both payer and provider organizations by providing quick access to accurate information from medical records and streamlining critical processes such as utilization management, appeals, referrals and order intake, and clinical trial eligibility checks. The UiPath Medical Record Summarization agent is already deployed by a major healthcare payer, which is using the agent to improve speed and accuracy of document processing to achieve results 23% faster. UiPath Medical Records Summarization delivers: Clinician-level summaries organized in easy-to-understand segments with traceable citations. Records are displayed in an organized format, enabling quick location and review of relevant information State-of-the-art retrieval-augmented generation (RAG) for processing unstructured medical record data, projected to deliver faster chart processing from intake to summary Reduction of administrative tasks for both clinical and non-clinical professionals UiPath partnership with Google Cloud Vertex AI makes it easy to build, deploy, and manage ML models and generate fast, cost-effective predictions. UiPath customers can now harness the power of the latest ML models through Vertex AI to build into business processes quickly and seamlessly without the need for complex coding and manual effort. UiPath is available on Google Cloud Marketplace to enable Google Cloud customers to purchase the industry-leading UiPath Platform and reliably deploy and scale their automation initiatives on Google Cloud infrastructure. Today, customers can deploy UiPath Studio and UiPath automations on Google Cloud in minutes. UiPath also recently expanded its partnership with Google Cloud to help customers facilitate their AI-powered automation journey through Google Workspace business collaboration offerings. Visit here to learn more about innovating with UiPath and Google Cloud. About UiPath UiPath (NYSE: PATH) develops AI technology that mirrors human intelligence with ever-increasing sophistication, transforming how businesses operate, innovate, and compete. The UiPath Platform™ accelerates the shift toward a new era of agentic automation -- one where agents, robots, people, and models integrate seamlessly to enable autonomous processes and smarter decision making. With a focus on security, accuracy, and resiliency, UiPath is committed to shaping a world where AI enhances human potential and revolutionizes industries. For more information, visit www.uipath.com.

UiPath launches AI tool to cut healthcare admin time By Investing.com

NEW YORK & LAS VEGAS - UiPath (NYSE: PATH), a prominent enterprise automation software firm, revealed the introduction of its new AI-based medical record summarization tool at Google Cloud Next 2025. The agent, designed to streamline healthcare administrative tasks, is currently in private preview with select customers. The UiPath Medical Record Summarization AI agent is engineered in collaboration with leading clinical professionals and is powered by Google Cloud Vertex AI and Gemini models. It aims to provide efficient, clinician-level multi-point summarization of extensive medical records, potentially reducing the average 45-minute manual data entry process to just minutes. Healthcare organizations stand to benefit significantly from this innovation, with potential outcomes including a 50% reduction in prior authorization turn-around time and up to 40 minutes saved per patient referral. The tool not only promises to cut down the time spent on patient referral intake, order intake, and utilization management reviews but also to improve the consistency and quality of medical summaries, thereby enhancing clinical decision-making and reducing errors. For investors seeking deeper insights, InvestingPro offers comprehensive analysis with 13 additional ProTips and a detailed Pro Research Report, part of its coverage of over 1,400 US stocks. The agent's deployment has already commenced with a major healthcare payer, resulting in a 23% improvement in document processing speed. UiPath's solution is part of its broader strategy to deliver industry-specific vertical AI solutions, with the healthcare sector being a key focus due to the intense pressure on Chief Medical Officers, Chief Financial Officers, and CIOs to reduce costs and improve the quality of care. UiPath's partnership with Google Cloud facilitates the integration of advanced machine learning models into business processes via Vertex AI, eliminating the need for complex coding and extensive manual effort. The UiPath Platform is also available on the Google Cloud Marketplace, allowing Google Cloud customers to implement and scale their automation initiatives on Google Cloud infrastructure with ease. This announcement is based on a press release statement and provides an overview of UiPath's strategic direction and its contributions to healthcare automation, highlighting the potential impact on efficiency and quality of care within the industry. The company's solid financial position is evident in its current ratio of 2.93 and steady revenue growth of 9.3% over the last twelve months, suggesting strong operational execution alongside its technological innovations. In other recent news, UiPath Inc. has reported financial results that did not meet expectations, with both Annual Recurring Revenue (ARR) and revenue figures falling short. This performance has led several firms to adjust their outlooks on the company. BMO Capital Markets lowered its price target for UiPath from $16.00 to $11.50 while maintaining a Market Perform rating, citing concerns over the company's growth prospects and the competitive landscape. Similarly, TD Cowen reduced its price target from $16.00 to $12.00, maintaining a Hold rating due to uncertainties and market volatility impacting UiPath's fiscal year 2026 outlook. RBC Capital Markets also adjusted its price target for UiPath to $13.00 from $16.00, keeping a Sector Perform rating, following disappointing results and outlook, particularly in Net New Annual Recurring Revenue (NNARR). Truist Securities revised its price target to $12.00 from $14.00, maintaining a Buy rating, while noting mixed fourth-quarter results affected by macroeconomic volatility and public sector hesitancy. Despite these challenges, Truist highlighted positive traction in UiPath's artificial intelligence products and go-to-market reorganization efforts. Additionally, Needham maintained a Hold rating after UiPath's AI Summit, where the company announced new strategic visions and technological advancements set to launch in April. Analysts at Needham anticipate these innovations will influence bookings primarily in 2026. Collectively, these developments reflect a cautious outlook from analysts, with a focus on UiPath's ability to navigate current challenges and capitalize on its technological advancements.